Similar findings demonstrating intra-tumor and intra-sample heterogeneity of receptor tyrosine kinase amplification (including HER2, EGFR and FGFR2) expression in gastric cancer, have previously been reported [19-22]. The gene discussed is FGFR2; the disease is gastric cancer.